Contributing to this we previously supposed that activation of melanoma cells by S100 proteins takes place by RAGE downstream signalling activation of NF‐κB as we demonstrated an increased NF‐κB activation caused by the treatment with recombinant S100A4 17. The gene discussed is AGER; the disease is melanoma.